In addition, recent evidence suggests that heterozygous BRCA1 mutant cells have an exaggerated response to estrogen induced DNA damage, providing a possible explanation of the cancer tissue specificity seen in BRCA carriers [16]. This evidence concerns the gene BRCA1 and cancer.